Allogeneic vs. autologous mesenchymal stem/stromal cells in their medication practice

Mesenchymal stem/stromal cell (MSC)-based therapeutics is already available for treatment of a range of diseases or medical conditions. Autologous or allogeneic MSCs obtained from self or donors have their own advantages and disadvantages in their medical practice. Therapeutic benefits of using auto...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chenghai, Zhao, Hua, Cheng, Linna, Wang, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561357/
https://www.ncbi.nlm.nih.gov/pubmed/34727974
http://dx.doi.org/10.1186/s13578-021-00698-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561357/
https://www.ncbi.nlm.nih.gov/pubmed/34727974
http://dx.doi.org/10.1186/s13578-021-00698-y

Ejemplares similares